1,179
Views
15
CrossRef citations to date
0
Altmetric
Research Article

QSAR model for predicting the fungicidal action of 1,2,4-triazole derivatives against Candida albicans

&
Pages 696-701 | Received 10 Aug 2009, Accepted 02 Dec 2009, Published online: 30 Apr 2010
 

Abstract

QSAR analysis of a series of previously synthesised 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols(TDFPP) as analogues of fluconazole were tested for growth inhibitory activity against Candida albicans using computer assisted multiple regression analysis. This was in order to explore the selectivity requirements for fungicidal activity against C. albicans among these congeners. A training set comprising 40 analogues and a test set comprising ten analogues of 1-(1H-1, 2, 4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols were selected for the present investigation by using the sphere exclusion method embedded in the Vlife MDS 3.5 software. With respect to the modelling of the growth inhibitory activity of the reported compounds, the regression analysis shows that even in the mono-parametric correlations the topological and physicochemical parameters give significant regression coefficients. The validation of the QSAR models was performed by cross-validation and external test set prediction. The model is not only able to predict the activity of new compounds but also explains the important region in the molecules in a quantitative manner.

Acknowledgements

The authors would like to thank Vlife Company for providing such user friendly software. The authors would also like to thank Xiaoyun Chai et al, Takuya Uchida and colleagues for providing the study literature.

Declaration of interest

The authors would like to thank Manipal University for funding of the software. The authors have no conflicting financial interests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.